Sleep is reflected not only in the electroencephalogram but also in heart rhythms and breathing patterns. Therefore, we hypothesize that it is possible to accurately stage sleep based on the electrocardiogram (ECG) and respiratory signals.
Introduction
Characterizing sleep has primarily relied on the analysis of the electroencephalogram (EEG), supplemented by the electrooculogram and chin electromyogram 1 . Three distinct states are readily discernable through such analysis: wake, rapid eye movement sleep (REM) and non-REM sleep (NREM) 1 . Three stages of progressive depth (N1, N2, and N3) can be differentiated in NREM 1 . EEG slow-wave oscillations (about 1 -4Hz) dominate deeper NREM sleep, while sleep spindles (about 10 -13 Hz) and theta wave oscillations (about 4 -8Hz) dominate lighter NREM sleep 1 .
Cortical, subcortical, and brainstem systems are highly interactive throughout sleep [2] [3] [4] [5] [6] , and their activity couples autonomic activity with the cortical activity measurable by EEG. Examples include strong sinus arrhythmia 3 , blood pressure dipping 7 , and stable breathing or stable flow-limitation 8 . REM sleep is characterized by highly recognizable respiratory rate and tidal volume fluctuations, and by surges in heart rate and blood pressure 9 . Wake demonstrates dominance of low-frequency heart rate variability and large amplitude movements. These observations suggest that accurate sleep staging might be possible from non-EEG signals influenced by the autonomic nervous system, such as the ECG or respiratory signals.
An accurate non-EEG method for staging state characterization would have several advantages. For example, the ECG is recorded continuously in numerous medical and situations, especially in hospitalized patients. Wearable devices increasingly measure ECG and respiration [10] [11] [12] . Cardiorespiratory signals may be obtainable in a number of ways, including contact recordings such as Withings, ballistocardiogram 13 , or non-contact radar-type applications such as EarlySense 14 , and SleepScore 15 , etc. On the other hand, EEG can be highly abnormal in medically ill populations, making standard analysis difficult 16 .
Deep learning approaches can be used to accurately estimate sleep states. We previously showed that deep neural networks can learn to score conventional sleep stages based on EEG signals obtained during overnight PSG with an accuracy of 87.5% and a Cohen's kappa of 0.805, comparable to the performance of human sleep scoring experts 17 . Here we develop deep neural networks using ECG and/or respiratory signals to classify sleep stages. Our approach is based on convolutional neural network (CNN) in combination with long-short term memory (LSTM) recurrent neural network. It is trained on a large clinical dataset, which also accounts for patient heterogeneity, spanning a wide range of ages, medications and sleep disorders.
Methods

Dataset
The Partners Institutional Review Board approved retrospective analysis of polysomnograms (PSG), acquired in the Sleep Laboratory at Massachusetts General Hospital from 2009 to 2016, without requiring additional consent for use in this study. PSGs were recorded adhering to American Academy of Sleep Medicine (AASM) standards. Each PSG includes one ECG channel and two respiratory effort channels recorded from chest and abdomen belts. The sampling frequency is 200 Hz for all signals. The dataset contains three major types of sleep tests: diagnostic, full-night continuous positive airway pressure (CPAP), and split-night CPAP. PSGs were annotated in 30-second non-overlapping epochs according to AASM standards as one of the five stages: wake (W), non-REM stage 1 (N1), non-REM stage 2 (N2), non-REM stage 3 (N3), and rapid eye movement (REM). Seven sleep technicians in total annotated the dataset, with one technician per PSG.
The entire dataset includes 10,121 PSGs; 9,644 were exported successfully without time mismatch or missing sleep stage annotations. We included atrial fibrillation cases because the deep learning network is supposed to work with heterogeneous data. We excluded PSGs with fewer than 100 artifact-free 30second epochs, resulting in 8,682 PSGs. The dataset is summarized in Table 1 . Figure S1 in the supplementary material.
When using ECG as the input, we identified 270-second epochs with amplitude larger than 6mV or standard deviation smaller than 5μV, as they are not physiologically possible. In each 270-second epoch we extracted timings of R peaks 18 and converted the ECG to a binary sequence, where R peaks are indicated by a "1" and all other points indicated by "0". The 270-second epochs with spurious R peaks were identified using the ADARRI 19 method. 270-second epochs with less than 20 R peaks per minute were also identified, as they are not physiologically possible. About 25% of the 270-second epochs were identified as artifact. In total, there were 5,964,359 270-second epochs.
When using chest and abdominal respiratory effort as the input, 270-second epochs with amplitude larger than 6mV or standard deviation smaller than 10μV were identified. Respiratory signals were down-sampled to 10Hz. About 10% of the 270-second epochs were identified as artifact. In total, there were 6,847,246 270-second epochs for the chest signal; and 6,749,286 270-second epochs for the abdominal signal.
When using pairs of signals as the input, the 270-second epochs where any signal modality that meet the above criteria are identified as artifact. In any of above cases, the artifactual 270-second epochs were removed when training CNN, and remained when training LSTM to preserve the temporal context.
with ECG as input, the LSTM has two layers with 20 hidden nodes in each layer. For CHEST and ECG+CHEST, the LSTM has three layers with 100 hidden nodes in each layer. For ABD and ECG+ABD, the LSTM has two layers with 100 hidden nodes in each layer. The number of LSTM layers, number of hidden nodes, and dropout rate were determined by the method described in the next subsection. The output is fed into a bidirectional LSTM, followed by concatenation of the activations from both directions, and finally into a dense layer. The legends on the right show the detailed structure of the residual block and final output block. Inside each residual block, the first convolution layer subsamples the input by 4 (stride = 4) and the max pooling skip-layer connection also subsamples the input by 4.
Training and Evaluating the Network
We randomly split the PSGs into a training set of 6,682 PSGs, a validation set of 1,000 PSGs and a testing set of 1,000 PSGs. Due to the large amount of data, we expect the random split should give similar distribution of the variables across these sets. We first trained the CNN, then the LSTM using the outputs from the CNN. The objective function of both CNN and LSTM is cross-entropy, a measure of the distance between two categorical distributions for classification. The networks were trained with a minibatch size of 32, maximum epochs of 10, and learning rate 0.001 (as commonly used in deep learning).
The LSTM was trained using sequences of 20 epochs (10min). We set the number of LSTM layers, number of hidden nodes, and the dropout rate as the combination that minimizes the objective function on the validation set.
Some sleep stages occur more frequently than others. For example, people spend about 50% of sleep in N2 and 20% in N3. To prevent the network from simply learning to report the dominant stage, we weighed each 270-second input signal in the objective function by the inverse of the number of epochs in each sleep stage within the training set.
For the performance metrics on the testing set, we used confusion matrices and Cohen's kappa. We show performance for staging five sleep stages according to the AASM standards (W, N1, N2, N3, R), and we additionally collapse these stages into 3 sleep super-stages, in two different ways. The first set of super-stages is "awake or drowsy" (W+N1) vs. "sleep" (N2+N3) vs. "REM sleep" (R), and The second set of super-stages is "awake" (W) vs. "NREM sleep" (N1+N2+N3) vs. "REM sleep" (R). We obtained 95% confidence intervals for kappa values by bootstrapping (sample with replacement) 1,000 times.
Results
Overall Staging Performance
In Figure 2 , we show the confusion matrices for predicting all five sleep stages with different input signals. Using both ECG and ABD as input signals yields the best prediction results on the testing set. This network is correct in 81.8% of wake, 55.8% of N1, 66.3% of N2, 66.6% of N3 and 92.2% of REM epochs. Most misclassifications are found between W vs. N1, N1 vs. N2, and N2 vs. N3. For example, 31% of N3 epochs are misclassified as N2, and 34% of N1 epochs are misclassified as either W or N2. This limitation is reduced when grouping the sleep stages as in Figure 3 and Figure 4 , so that both epochs of REM and NREM can be classified correctly with greater than 80% accuracy. For every choice of input signal, we calculated Cohen's kappa, a statistic for assessing inter-reader agreement, and the corresponding 95% confidence intervals. These are shown in Table 2 . ECG+ABD has the highest kappa, with values of 0.6 (all five stages), 0.74 (W+N1 vs. N2+N3 vs. REM) and 0.762 (Wake vs. NR vs. REM). Since the testing set has 1,000 PSGs (6.6×10 5 30-second epochs), the confidence interval is narrow. Therefore the differences between kappa values are all significant at 0.05 level. 
Staging Performance on Different Groups of Participants
In Table 3 , we show Cohen's kappa for different population groups in the testing set using ECG+ABD as the input signals. Kappa is lower in the elderly (≥ 60 years) and in people with higher Apnea-Hypopnea Index (AHI), compared to the respective control groups. Split-night studies have lower kappa values than diagnostic or CPAP nights due to different patterns before and after applying CPAP. Note again that due to the large number of epochs in the testing set, confidence intervals are narrow, and all comparisons are statistically significant at 0.05 level. The Cohen's kappa for different population groups in the testing set using other input signals are shown in Table E1 -E4 in the supplementary material.
While performance is reduced with increasing AHI, the network still achieves Cohen's kappa of 0.574 for five stages; and more than 0.7 for three super-stages for severe apnea. We interpret this to mean that either autonomic features characteristic of stages are independent of sleep apnea, or more likely, that the network has learned normal, apneic, and other pathological patterns of the respiration signals change according to sleep stage. For example, REM and NREM interruptions in breathing may have distinct distributions of features such as event duration. 
Staging Performance on Individual PSGs
In Figure 5 , we show the histogram of Cohen's kappa of each individual PSG using both ECG and ABD as input. The results indicate a fair amount of heterogeneity between PSGs, where the lowest extreme has negative kappa values around -0.1 and the highest extreme has kappa values around 0.9. In Figure S2 in the supplementary material, we show the Cohen's kappa of each individual PSG using all signal types. 
Dependence on temporal precision of R-peak timing in the ECG
In face of signal noise, the deep learning network should learn robust patterns of the ECG R peak time series. To validate its robustness to signal noise, we simulated noise that preserves the mean but corrupts higher order pattern of the ECG R peaks. In Figure S3 of the supplementary material, we can see that adding zero-mean Gaussian jitter to the R peaks causes performance to drop progressively as the standard deviation of the jitter increases.
Signal Examples
To gain some insight into the differences in breathing and heart rhythms that the deep neural network is using to distinguish sleep stages, we show some example whole night recordings from the 1000-PSG testing set in Figure 6 , Figure 7 , and Figure 8 . These examples are selected as "typical", meaning that they have the closest Cohen's kappa compared to the overall kappa across the testing set. The 60second signal examples in Panel C are the signals where the deep neural network assigns the highest probability to the correct sleep stage within the recording. We can see a visible correspondence between the spectrogram and the sleep stages, as well as the mismatch between the spectrogram and EEG-based sleep stage. For example, in Figure 8 , around 2 hours and 4.5 hours, the spectrogram of heart rate variability shows loss of very low frequency power, which is classified by the network as N3, but the EEG-based sleep stages contain both N2 and N3. More illustrations of the trained deep neural networks are shown in Figure S4 -S12 of the supplementary material. Figure 6 , but amplitude of these example signal itself happens to be smaller. It is possible that other epochs have larger or similar amplitude compared to Figure 6 . 
Discussion
We hypothesize that it is possible to accurately stage sleep based on the electrocardiogram (ECG) and respiratory signals using deep learning. Our key findings are: 1) ECG and respiratory signals contain substantial information about sleep stages; 2) reduced staging accuracy is associated with older age and/or more severe sleep apnea, although the networks still perform well on signals from patients with advanced age and high AHI; 3) using deep learning, the staging performance is robust for a wide range of typical sleep disorders like OSA and PLMS, and commonly used medications; 4) collapsing certain stages of sleep/wake (e.g., N1 with wake and N2 with N3) results in greater staging agreement.
Previous studies comparable to ours are summarized in Table 4 . Some prior studies have also sought to stage sleep from ECG and respiration using deep neural networks. However, these studies suffered from small sample sizes and limiting generalizability. Only one prior study used more than 100 participants for training and evaluation. The large sample size of training and testing sets in the present study provides more robust results compared to prior literature, and is expected to increase generalizability when applied to heterogeneous / external populations. Sleep staging based on ECG and respiration has lower performance compared to using EEG. We previously performed EEG-based sleep staging with a deep neural network trained on data from the same set of patients used in the present work. This achieves performance similar to human inter-rater agreement 17 . This is not surprising since sleep technicians stage sleep mainly using EEG based on the AASM guideline.
The improvement in staging performance when collapsing certain stages of sleep into super-stages may reflect information regarding the true biology of sleep states. N1 is an unstable transitional state with low probability and non-distinct EEG features. About half of sleep is N2, and can show both stable and unstable characteristics, such as cyclic alternating pattern, apneic, or stable breathing in patients with sleep apnea. Different methods to characterize sleep depth and quality are available, and it will be important in future work to investigate whether further parsing of NREM sleep is meaningful using machine learning combined with methods such as the Odds Ratio Product of NREM sleep depth 27 or ECG-cardiopulmonary coupling 8 .
The mild degradation of performance with age is not surprising when using conventional sleep stages as the ground truth. The reduction of N3 with age (mainly in males) is not accompanied by equal and simultaneous reductions in stable N2 -thus, older individuals with equally reduced N3 may have very different N2 quality. By contrast, stable N2 and N3 may have very similar or identical cardiorespiratory signatures, making it difficult or impossible for deep learning models to reliably distinguish them. Thus "errors" in discriminating these stages may reflect that EEG-based annotation in the reference standard is somewhat orthogonal to autonomic fluctuations.
Estimation of sleep states from cardiac and respiratory signals can simplify sleep tracking in health and disease, especially in environments like an intensive care unit (ICU) or hospitalized patients in general, when the model is trained with enough ICU patients who receive various heart rate or blood pressure medications.
Limitations of our analysis are as follows. 1) Our dataset includes only adults, and generalizability to the pediatric group will require additional study. Figure S4 -S12 in the supplementary material) is needed. (4) 1-fold validation (single training-validation-testing split) is used. Although this is the common practice in large datasets, it is nevertheless less biased to use cross-validation on multiple folds.
In conclusion, utilizing a large-scale dataset consisting of 8,682 PSGs, we have developed a set of deep neural networks to classify sleep stages from ECG and/or respiration. ECG and respiratory effort provide substantial information about sleep stages. The best staging performance is obtained using both ECG and abdominal respiration. Staging performance depends to some extent on age, apnea-hypopnea index, and sleep study type. Figure S1 . Illustration of signal segmentation. 
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